name: "Zehui Bai"                                
output_dir: "."
navbar:
  title: "Zehui Bai"                             
  type: inverse
  left:
    - text: "Home"
      icon: fa-home
      href: index.html
    - text: "Clinical Experience"
      icon: fa-user 
      href: 02-Clinical_Experience.html
    - text: "Sample Size"
      icon: fa-sliders 
      menu:
      - text: Everything to Know About Sample Size Determination
        href: 03-SSC-Everything-to-Know-About-Sample-Size-Determination.html
      - text: Choosing the Effect Size
        href: 03-SSC-Choosing-the-Effect-Size-for-Sample-Size-Calculations.html
      - text: Statistical Considerations for the Design and Analysis of Biosimilar Trials
        href: 03-SSC-Biosimilar-Trials.html 
      - text: Sample Size and Power for Non-Parametric Analysis
        href: 03-SSC-Sample-Size-and-Power-for-Non-Parametric-Analysis.html
      - text: Power for Complex Hypotheses
        href: 03-SSC-Power-for-Complex-Hypotheses.html
      - text: Bayesian methods - Alternatives to Power
        href: 03-SSC-Alternatives-to-Power.html
      - text: Sample Size for Pilot Studies
        href: 03-SSC-Sample-Size-for-Pilot-Studies.html

      - text: Sample Size Determination for Continuous Endpoint
        href: 03-SSC-Case-Continuous-Endpoint.html
      - text: Sample Size Determination for Categorical Endpoint
        href: 03-SSC-Case-Categorical-Endpoint.html
      - text: Sample Size Determination for Counts and Rates
        href: 03-SSC-Sample-Size-Determination-for-Counts-and-Rates.html
      - text: Sample Size Determination for Survival Endpoint
        href: 03-SSC-Case-Survival-Endpoint.html
      - text: Sample Size Determination for Repeated Measures
        href: 03-SSC-Case-Repeated-Measures.html

      - text: Statistical Considerations for Group Sequential Design
        href: 03-SSC-IA-Sequential-Design.html        
      - text: Statistical Considerations for Adaptive Design
        href: 03-SSC-IA-Adaptive-Design.html
      - text: Sample Size for Multiple Test
        href: 03-SSC-Multiple-Test.html
        
    - text: "Study Design"
      icon: fa-pencil-square-o 
      menu:
      - text: General Consideration
        href: 04-Design-General-Consideration.html
      - text: Estimands Framework
        href: 04-Design-Estimands-Framework.html
      - text: Estimands and Sensitivity Analyses
        href: 04-Design-Estimands-Practice.html

      - text: Phase I Trials - Design Considerations
        href: 04-Design-Phase-I-Trials---Design-Considerations.html
      - text: Phase II Trials - Design Considerations
        href: 04-Design-Phase-II-Trials---Design-Considerations.html
      - text: Phase III Trials - Design Considerations
        href: 04-Design-Phase-III-Trials---Design-Considerations.html
      - text: Phase IV Trials - Design Considerations for Post Marketing Surveillance
        href: 04-Design-Phase-IV-Trials---Design-Considerations.html

      - text: Complex Sequential Analysis Trials
        href: 04-Design-Complex-Sequential-Trials.html
      - text: Adaptive Clinical Trials
        href: 04-Design-Adaptive-Clinical-Trials.html
      - text: Bayesian Clinical Trials
        href: 04-Design-Bayesian-Clinical-Trials.html

      - text: Dose Escalation and Stratification Designs in Early Oncology Development
        href: 04-Design-Dose-Escalation-and-Stratification-Designs.html
      - text: Single Arm Clinical Trials
        href: 04-Design-Single-Arm-Clinical-Trials.html
      - text: Diagnostic Study-Design and Evaluation
        href: 04-Design-Diagnostic-Study-Design-and-Evaluation.html
      - text: Diagnostic Study-Multireader Multicase (MRMC)
        href: 04-Design-Diagnostic-Study-MRMC.html
      - text: Vaccine Trials
        href: 04-Design-Vaccine-Design.html
        
      - text: Externally Controlled Trials
        href: 04-Design-Externally-Controlled-Trials.html
      - text: Noninferiority Trials
        href: 04-Design-Noninferiority-Trials.html
      - text: Bioequivalence and Biosimilar Trials
        href: 04-Design-Bioequivalence-and-Biosimilar-Trials.html
      - text: Exploring Survival Analysis Designs for Clinical Trials
        href: 04-Design-Exploring-Survival-Analysis-Designs-for-Clinical-Trials.html
      - text: Hierarchical Composite Endpoints
        href: 04-Design-Hierarchical-composite-endpoints.html
      - text: Regulatory Submission from Stats Perspective
        href: 04-Design-Regulatory-Submission.html
        
    - text: "Data Visualization"
      icon: fa-line-chart 
      menu:
      - text: Time to Event Data Visualization
        href: 05-Plot-Time-To-Event.html
      - text: Patient Reported Outcome Data Visualization
        href: 05-Plot-PRO-Data.html
      - text: Sample Size and Power Calculations Visualization
        href: 05-Plot-SSC-and-Power-Calculation.html     
      - text: Correlation Visualization
        href: 05-Plot-Correlation.html     
      - text: Clinical Data and Model visualization
        href: 05-Plot-Model-Table.html
        
      - text: Scatter and Line Plot
        href: 05-Plot-ScatterPlot.html
      - text: Bar Chart
        href: 05-Plot-BarPlot.html
      - text: Pie Chart
        href: 05-Plot-PieChart.html
      - text: Box Plot
        href: 05-Plot-BoxPlot.html
      - text: Histogram
        href: 05-Plot-Histogram.html
      - text: Forest Plot
        href: 05-Plot-Forest-Plot.html
      - text: Flow Chart
        href: 05-Plot-Flow-Chart.html
      - text: Some Interesting Plots
        href: 05-Plot-Some-Interesting.html

        
    - text: "Statistical Analysis"
      icon: fa-calculator
      menu:
      - text: Linear Regression
        href: 06-Analysis-Linear-Regression.html
      - text: Logistic Regression
        href: 06-Analysis-Logistic-Regression.html
      - text: Mixed Model
        href: 06-Analysis-Mixed-Model.html
      - text: Mixed Model Repeated Measures
        href: 06-Analysis-MMRM.html
      - text: Generalized Estimating Equation
        href: 06-Analysis-GEE.html
      - text: Analysis of Variance
        href: 06-Analysis-ANOVA.html
      - text: Survival Analysis
        href: 06-Analysis-Survival-Analysis.html
      - text: Survival Analysis - Competing Risk
        href: 06-Analysis-Survival-Competing-Risk.html
        
      - text: Missing Data Analysis
        href: 06-Analysis-Missing-Data.html
      - text: Multiple Imputation Analysis
        href: 06-Analysis-MI-Implementation.html

      - text: Safety Signal Detection and Evaluation
        href: 06-Analysis-SSD.html        
      - text: Meta Analysis
        href: 06-Analysis-Meta-Analysis.html
        
      - text: PK and PD Analysis
        href: 06-Analysis-PK-and-PD.html
      - text: Time Series Analysis
        href: 06-Analysis-Time-Series-Analysis.html
      - text: Structural Equation Modeling
        href: 06-Analysis-SEM.html
      - text: Factor Analysis
        href: 06-Analysis-Factor-Analysis.html
      - text: Propensity Score Analysis
        href: 06-Analysis-Propensity-Score.html

    - text: "Machine Learning"
      icon: fa-bar-chart
      menu:
      - text: Bayesian Theory                                     
        href: 07-ML-Bayesian-Theory.html
      - text: Bayesian Analysis
        href: 07-ML-Bayesian-Analysis.html
      - text: Regularization Penalized Regression 
        href: 07-ML-Regularization-Penalized-Regression.html
      - text: Loss Functions in Machine Learning 
        href: 07-ML-Loss-Regression.html
      - text: Principal Component Analysis
        href: 07-ML-PCA.html
      - text: K-Nearest Neighbors
        href: 07-ML-KNN.html
      - text: Support Vector Machine
        href: 07-ML-SVM.html
      - text: Tree Models
        href: 07-ML-Tree-Models.html
      - text: Linear Discriminant Analysis
        href: 07-ML-LDA.html
      - text: Cluster Analysis
        href: 07-ML-Cluster-Analysis.html
      - text: Neural Network
        href: 07-ML-Neural-Networks.html
        
    - text: "Clinical Analysis (ADaM)"
      icon: fa-stethoscope
      menu:
      - text: Disposition and Baseline
        href: 08-Clinical-Disposition-Baseline.html
        
      - text: Efficacy Analysis 
        href: 08-Clinical-Efficacy.html
         
      - text: Pharmacokinetics Analysis
        href: 08-Clinical-Pharmacokinetics-Analysis.html
        
      - text: Adverse Event Visualization
        href: 08-Clinical-Adverse-Event.html
        
      - text: Laboratory Data Visualization
        href: 08-Clinical-Laboratory-Data.html
        
  right:
    - text: "CV"
      icon: fa-file-pdf-o
      href: 08-CV.html
    - text: "Contact me"
      icon: fa-envelope-o
      href: mailto:zehuibai@outlook.com                 
    - text: "GitHub"
      icon: fa-github
      href: https://github.com/Zehuibai              
output:
  html_document:
    theme: cerulean
    highlight: textmate